Search results for "Scarce data"

showing 4 items of 4 documents

New distributional data for the Mediterranean medicinal leech Hirudo verbana Carena, 1820 (Hirudinea, Hirudinidae) in Italy, with a note on its feedi…

2021

Author(s): Marrone, Federico; Alfonso, Giuseppe; Barbagallo, Rosario; Brandmayr, Pietro; Bruni, Giacomo; Costa, Simone; Farina, Giovanni; Gerecke, Reinhard; Iannarelli, Angelina; Mazza, Giuseppe; Mazzei, Antonio; Menchetti, Mattia; Moretti, Valerio; Mori, Emiliano; Novaga, Riccardo; Pecoraro, Marco; Schifani, Enrico; Stoch, Fabio; Vecchioni, Luca | Abstract: Scarce data are currently available about the distribution of the Mediterranean medicinal leech Hirudo verbana in Italy, and most of the known occurrence localities are based on records collected in the nineteenth and the first half of the twentieth century, which were not confirmed in the last decades, mostly due to a lack of surveys. …

Mediterranean climateScarce dataGlobal and Planetary ChangeEcologybiologyMonitoringbusiness.industryAnnelidaHabitats directiveSettore BIO/05 - ZoologiaDistribution (economics)LeechHirudoBaseline databiology.organism_classificationHabitats DirectiveGeographyFeeding behaviourEthnologyHabitats DirectivebusinessHirudo verbanaEcology Evolution Behavior and Systematics
researchProduct

Semi-ResMass Study: Residual masses after salvage chemotherapy in men with pure seminoma—A multicenter retrospective analysis.

2020

420 Background: Only scarce data exist on the management of residual masses in men who have received two lines of chemotherapy for advanced seminoma. Due to the lack of data, the role of PET scanning, surgery and other additional treatments is controversial in these men. Methods: Data from men with pure seminoma and residual masses after salvage chemotherapy were retrospectively collected from 10 high-volume centers in 3 European countries. We analyzed the clinical management of residual masses (imaging, surgery, pathological data, and additional treatment modalities) and long-term outcomes. Residual mass was defined as a lesion of ≥1 cm after two lines of platin-based chemotherapy. Result…

Scarce dataCancer ResearchChemotherapymedicine.medical_specialtybusiness.industrymedicine.medical_treatmentSalvage treatmentSeminomamedicine.diseaseOncologymedicineRetrospective analysisRadiologybusinessJournal of Clinical Oncology
researchProduct

A new methodology for Functional Principal Component Analysis from scarce data. Application to stroke rehabilitation.

2015

Functional Principal Component Analysis (FPCA) is an increasingly used methodology for analysis of biomedical data. This methodology aims to obtain Functional Principal Components (FPCs) from Functional Data (time dependent functions). However, in biomedical data, the most common scenario of this analysis is from discrete time values. Standard procedures for FPCA require obtaining the functional data from these discrete values before extracting the FPCs. The problem appears when there are missing values in a non-negligible sample of subjects, especially at the beginning or the end of the study, because this approach can compromise the analysis due to the need to extrapolate or dismiss subje…

Scarce dataFunctional principal component analysisPrincipal Component AnalysisComputer scienceProcess (engineering)Stroke RehabilitationSample (statistics)Missing datacomputer.software_genreStrokePrincipal component analysisHumansData miningcomputerAnnual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference
researchProduct

Universal newborn hearing screening in the Italian Region of Sicily in 2018

2021

We have clarified the role of Universal Neonatal Hearing Screening (UNHS) for both early diagnosis and rapid treatment in order to improve the prognosis of the deaf child and reduce patient management costs. Although in Sicily UNHS has been progressively implemented, there is scarce data in the literature on this matter. Therefore, the main objective was to collect in the year 2018 the following data: number of newborns screened for hearing loss, number of infants "referred" to transiently evoked otoacoustic emissions (TEOAE), number of infants with pathologic auditory brainstem response (ABR) and number of infants affected by permanent hearing loss.UNHS monitoring was conducted through the…

Scarce dataPediatricsmedicine.medical_specialtyHearing lossOtoacoustic Emissions SpontaneousHearing screeningcongenital deafnessscreening universale uditivo neonataleNeonatal ScreeningCongenital deafness Neonatal hearing loss Universal newborn hearing screening Child Evoked Potentials Auditory Brain Stem Hearing Tests Humans Infant Newborn Otoacoustic Emissions Spontaneous Sicily Hearing Loss Neonatal ScreeningEpidemiologyEvoked Potentials Auditory Brain StemmedicineHumansneonatal hearing lossCongenital deafness; Neonatal hearing loss; Universal newborn hearing screening; Child; Evoked Potentials Auditory Brain Stem; Hearing Tests; Humans; Infant; Infant Newborn; Otoacoustic Emissions Spontaneous; Sicily; Hearing Loss; Neonatal ScreeningChildHearing LossEvoked PotentialsAuditorySicilyNeonatal hearing lossbusiness.industrySpontaneousHearing TestsBilateral hearing lossInfant NewbornInfantAudiologyNewbornuniversal newborn hearing screeningsordità congenitaPatient managementcongenital deafness; neonatal hearing loss; universal newborn hearing screening.General EnergyAuditory brainstem responseipoacusia neonataleOtorhinolaryngologymedicine.symptombusinessOtoacoustic EmissionsBrain StemActa Otorhinolaryngologica Italica
researchProduct